Literature DB >> 20012362

Electronic screening of medical records to detect inpatients at risk of drug-related problems.

Isabelle Roten1, Stefan Marty, Johnny Beney.   

Abstract

OBJECTIVE: The objective of the study is to develop and validate a screening tool for clinical pharmacists (CPs), comprising electronic queries (EQs) structured to identify inpatients at risk of drug-related problems (DRPs) [1].
SETTING: Internal Medicine and Geriatric Units of the (multi-site) Hôpital du Valais.
METHOD: EQs, identifying patients with potential DRPs and/or those requiring a medication review were compared with a CP-conducted manual check of all electronic medical records (EMRs), during their standard activities. The queries were aimed at identifying patients receiving drugs such as cytochrome P450 inducers, inhibitors or high-risk medications, those with renal impairment, those on digoxin with low serum potassium, those with intravenous (i.v.) anti-infectives or i.v. acetaminophen for more than 3 days, and elderly patients with polymedication (>or=80 years and >10 drugs). MAIN OUTCOME MEASURE: Sensitivity and specificity of the screening tool.
RESULTS: Five hundred and one patients seen by 4 CPs during 36 ward rounds were screened. The EQs identified 64.7% of the visited inpatients. The CPs detected at least one DRP in 64.9% of all patients. A sensitivity of 85.1% and a specificity of 60.4% were achieved.
CONCLUSION: This tool allows for efficient and rapid screening of patients at risk of DRPs in preparation for the ward round. It helps CPs to prioritize their medication reviews and to optimize their workload.

Entities:  

Mesh:

Year:  2009        PMID: 20012362     DOI: 10.1007/s11096-009-9352-6

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  18 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Appropriateness of digoxin level monitoring.

Authors:  Mara R Mordasini; Stephan Krähenbühl; Raymond G Schlienger
Journal:  Swiss Med Wkly       Date:  2002-09-07       Impact factor: 2.193

Review 3.  An introduction to power and sample size estimation.

Authors:  S R Jones; S Carley; M Harrison
Journal:  Emerg Med J       Date:  2003-09       Impact factor: 2.740

4.  Reported medication errors associated with methotrexate.

Authors:  Thomas J Moore; Christopher S Walsh; Michael R Cohen
Journal:  Am J Health Syst Pharm       Date:  2004-07-01       Impact factor: 2.637

5.  Drug dosage adjustments according to renal function at hospital discharge.

Authors:  Elisabeth A van Dijk; Nathalie R G Drabbe; Martine Kruijtbosch; Peter A G M De Smet
Journal:  Ann Pharmacother       Date:  2006-06-27       Impact factor: 3.154

6.  Development of an intelligent decision support system for medication review.

Authors:  I K Bindoff; P C Tenni; G M Peterson; B H Kang; S L Jackson
Journal:  J Clin Pharm Ther       Date:  2007-02       Impact factor: 2.512

Review 7.  Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity.

Authors:  N M Buderer
Journal:  Acad Emerg Med       Date:  1996-09       Impact factor: 3.451

Review 8.  Drug-related problems in hospitals: a review of the recent literature.

Authors:  Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  An analysis of discharge drug prescribing amongst elderly patients with renal impairment.

Authors:  N A Wong; H W Jones
Journal:  Postgrad Med J       Date:  1998-07       Impact factor: 2.401

10.  Inappropriate medication use among frail elderly inpatients.

Authors:  Joseph T Hanlon; Margaret B Artz; Carl F Pieper; Catherine I Lindblad; Richard J Sloane; Christine M Ruby; Kenneth E Schmader
Journal:  Ann Pharmacother       Date:  2004-01       Impact factor: 3.154

View more
  9 in total

Review 1.  The scope of drug-related problems in the home care setting.

Authors:  Carla Meyer-Massetti; Christoph R Meier; B Joseph Guglielmo
Journal:  Int J Clin Pharm       Date:  2018-01-11

2.  High-risk medicines associated with clinically relevant medication-related problems in UK hospitals: A prospective observational study.

Authors:  Cathy Geeson; Li Wei; Bryony Dean Franklin
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

3.  Patient risk factors for developing a drug-related problem in a cardiology ward.

Authors:  Olatz Urbina; Olivia Ferrández; Sònia Luque; Santiago Grau; Sergi Mojal; Rosa Pellicer; Marta Riu; Esther Salas; Josep Comin-Colet
Journal:  Ther Clin Risk Manag       Date:  2014-12-17       Impact factor: 2.423

4.  Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists' input to improve patient outcomes. Protocol for an observational study.

Authors:  Cathy Geeson; Li Wei; Bryony Dean Franklin
Journal:  BMJ Open       Date:  2017-06-14       Impact factor: 2.692

5.  Facilitators and barriers for performing comprehensive medication reviews and follow-up by multiprofessional teams in older hospitalised patients.

Authors:  Thomas Gerardus Hendrik Kempen; Amanda Kälvemark; Maria Sawires; Derek Stewart; Ulrika Gillespie
Journal:  Eur J Clin Pharmacol       Date:  2020-02-19       Impact factor: 2.953

6.  Development and performance evaluation of the Medicines Optimisation Assessment Tool (MOAT): a prognostic model to target hospital pharmacists' input to prevent medication-related problems.

Authors:  Cathy Geeson; Li Wei; Bryony Dean Franklin
Journal:  BMJ Qual Saf       Date:  2019-03-07       Impact factor: 7.035

Review 7.  Clinical validation of clinical decision support systems for medication review: A scoping review.

Authors:  Birgit A Damoiseaux-Volman; Stephanie Medlock; Delanie M van der Meulen; Jesse de Boer; Johannes A Romijn; Nathalie van der Velde; Ameen Abu-Hanna
Journal:  Br J Clin Pharmacol       Date:  2021-12-15       Impact factor: 3.716

8.  Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort.

Authors:  Valdjane Saldanha; Rand Randall Martins; Sara Iasmin Vieira Cunha Lima; Ivonete Batista de Araujo; Antonio Gouveia Oliveira
Journal:  BMJ Open       Date:  2020-04-23       Impact factor: 2.692

9.  Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period.

Authors:  O Ferrández; S Grau; O Urbina; S Mojal; M Riu; E Salas
Journal:  Saudi Pharm J       Date:  2018-02-08       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.